COL4A1 mutations should not be a contraindication for epilepsy surgery

Area of Science:

• Neuroscience
• Genetics
• Vascular Biology

Background:

• Mutations in collagen type IV alpha 1 (COL4A1) gene compromise vascular basement membrane integrity.
• This genetic defect predisposes individuals to various neurological and vascular disorders, including epilepsy, stroke, and developmental delay.
• COL4A1 mutations are associated with an increased risk of intracranial hemorrhage, particularly in pediatric patients undergoing anesthesia.

Observation:

• A 6-year-old female with a confirmed COL4A1 mutation presented with drug-resistant epilepsy, cerebral palsy, and developmental delay.
• The patient was deemed a candidate for corpus callosotomy following comprehensive presurgical evaluation.
• Previous general anesthesia had been uneventful, and preoperative coagulation studies were within normal limits.

Findings:

• A complete corpus callosotomy was performed without any intracranial hemorrhage or other perioperative complications.
• Perioperative management focused on maintaining normotension and strictly avoiding anticoagulation.
• This represents the first documented instance of complication-free epilepsy surgery in a pediatric patient with a COL4A1 mutation.

Implications:

• The findings suggest that COL4A1 mutations, despite the associated hemorrhage risk, should not automatically contraindicate epilepsy surgery.
• Individualized patient assessment, careful risk-benefit analysis, and informed consent are crucial for managing these complex cases.
• This case expands the understanding of surgical management possibilities for epilepsy in patients with COL4A1-related vascular conditions.